HCC38 cell

SKU:BHC11101678
Bulk Pricing
Overview
Click light‑blue chips for details

HCC38 cell is a Epithelial cell cell line derived from Caucasian (Female). It is commonly used as an in vitro model for 1 research. Growth characteristics: Adherent, single cells and loosely attached cluster, Epithelial-like. Supplied as cryopreserved cells with accompanying batch CoA and quality-control documentation.

Species Human
Disease model Carcinoma
Morphology Epithelial-like
Growth Properties Adherent, single cells and loosely attached cluster
Tissue Breast
Options selector
Catalog no. Size
305307 1 cryovial
Available Options

This cell line is available in the U.S. For non-profit users, please sign and submit the Non-Profit Supply Agreement to orders@biohippo.com before placing an order. For commercial users, please complete the CLEAR Form before ordering, as additional usage fees may apply based on the intended use. For further details, please contact orders@biohippo.com. Products ship after the required agreement is completed; typical delivery is 2–3 business days. Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 10^6 cells for adherent lines or 5 × 10^6 cells for suspension lines (refer to the batch CoA for details).

Field Specification
Mfr No 305307
Species Human
The HCC38 cell line is a triple-negative breast cancer (TNBC) model characterized by its lack of estrogen receptor (ER), progesterone receptor (PR), and HER2 expression, making it a critical tool for studying aggressive breast cancer subtypes that do not respond to hormone or HER2-targeted therapies. HCC38 cells are particularly valuable for research into treatment resistance and the mechanisms driving TNBC progression. For instance, exposure to cisplatin can lead to the development of cisplatin-resistant subclones such as HCC38CisR, which exhibit increased activation of pro-survival pathways mediated by receptor tyrosine kinases (e.g., IGF1R and EGFR). This resistance can be counteracted by targeted therapies like NVP-BEZ235, a dual PI3K/mTOR inhibitor, which has shown potential to restore cisplatin sensitivity in HCC38CisR. In addition, the HCC38 cell line has been studied in the context of apoptosis and invasion mechanisms. The knockdown of specific genes, such as OC90, has been shown to significantly reduce cell viability and enhance apoptosis in HCC38, underlining the role of specific molecular targets in cell survival and invasive behavior. This feature is relevant for identifying novel therapeutic approaches for TNBC. Moreover, HCC38's response to treatment, including resistance mechanisms, highlights its utility for exploring drug combinations that could circumvent resistance and enhance treatment efficacy. Furthermore, studies with HCC38 have demonstrated the efficacy of small-molecule inhibitors in overcoming resistance when combined with conventional chemotherapeutics. For example, co-treatment strategies involving PI3K/mTOR inhibitors alongside traditional chemotherapy agents show promise in reducing proliferation rates and inducing apoptosis in resistant cell variants. Such findings contribute to the development of targeted therapies that address the challenges of treatment resistance in TNBC.

SKU:BHC11101678

  • Protein expression: epithelial glycoprotein 2 (EGP2), cytokeratin 19
  • Oncogenes: her2/neu-, p53+
  • Mutational profile: Mutation: TP53, p.Arg273Leu (c.818G>T), homozygous
  • cultureMedium: RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a)
  • supplements: Supplement the medium with 10% FBS
  • dissociationReagent: Accutase
  • subculturing: Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium.
  • fluidRenewal: 2 to 3 times per week
  • freezeMedium: As a cryopreservation medium, use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress.
Matches this product
10% OFF
10% OFF CELL LINES-Limited-Time Offer
Ends Sep 30 CELL10
15%OFF
15% Off Cancer Antibodies
Ends Sep 30 ONCO15
$50 OFF
$50 Off All ELISA Kits
Limited time ELISA50
FREE SAMPLE
Free Sample – CellTrypase Recombinant Trypsin-Like Enzyme
Limited time offer – availa... FREESAMPLE
FREE SAMPLE
Free Sample – MycoFold™ Growth Factors
Limited time offer – availa... Request Free Sample

Get a Quote

Please use this form for bulk quantity requests or customized products.

Contact Information

Product Information

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today